About 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide
2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide (PubChem CID 155551644) has the molecular formula C32H38Br2N6O4
and a molecular weight of 730.50 g/mol. Its IUPAC name is 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide.
Molecular Properties
| Compound Name | 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide |
| PubChem CID | 155551644 |
| Molecular Formula | C32H38Br2N6O4 |
| Molecular Weight | 730.50 g/mol |
| Exact Mass | 728.13 |
| IUPAC Name | 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide |
| SMILES | O=C(NCCCNCCCCCCNCCCNC(=O)C(=O)c1c[nH]c2cc(Br)ccc12)C(=O)c1c[nH]c2cc(Br)ccc12 |
| InChI | InChI=1S/C32H38Br2N6O4/c33-21-7-9-23-25(19-39-27(23)17-21)29(41)31(43)37-15-5-13-35-11-3-1-2-4-12-36-14-6-16-38-32(44)30(42)26-20-40-28-18-22(34)8-10-24(26)28/h7-10,17-20,35-36,39-40H,1-6,11-16H2,(H,37,43)(H,38,44) |
| InChIKey | JHIWLFJTTMHDJR-UHFFFAOYSA-N |
| XLogP | 4.99 |
| TPSA | 147.98 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 19 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 730.50 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Analyze 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide?
The IUPAC name of 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide (CID 155551644) is 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide.
What is the SMILES notation for 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide?
The canonical SMILES for 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide is O=C(NCCCNCCCCCCNCCCNC(=O)C(=O)c1c[nH]c2cc(Br)ccc12)C(=O)c1c[nH]c2cc(Br)ccc12.
What is the InChIKey of 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide?
The InChIKey is JHIWLFJTTMHDJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H38Br2N6O4/c33-21-7-9-23-25(19-39-27(23)17-21)29(41)31(43)37-15-5-13-35-11-3-1-2-4-12-36-14-6-16-38-32(44)30(42)26-20-40-28-18-22(34)8-10-24(26)28/h7-10,17-20,35-36,39-40H,1-6,11-16H2,(H,37,43)(H,38,44).
What are the key properties of 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide?
2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide has a molecular weight of 730.50 g/mol, XLogP of 4.99, 19 rotatable bonds, 6 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(6-bromo-1H-indol-3-yl)-N-[3-[6-[3-[[2-(6-bromo-1H-indol-3-yl)-2-oxoacetyl]amino]propylamino]hexylamino]propyl]-2-oxoacetamide is sourced from PubChem (CID 155551644), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).